DANVILLE, Pa., Nov. 8, 2018 /PRNewswire/ -- Geisinger today
announced that its Board of Directors has appointed Jaewon Ryu, M.D., J.D., as interim president and
chief executive officer of Geisinger, effective December 1, 2018. Dr. Ryu, who has served as
executive vice president and chief medical officer since
September 2016, succeeds David T. Feinberg, M.D., MBA, who is leaving
Geisinger January 3, 2019, to assume
a leadership role at Google. Dr. Feinberg will remain with
Geisinger until that time to help facilitate a smooth
transition.
Dr. Ryu has a deep understanding of the Geisinger organization
and culture in addition to his management and physician experience,
making him an ideal fit to lead the organization during this
transition. As chief medical officer, Dr. Ryu has overseen all
aspects of patient care at Geisinger, working to improve patient
access, expand our value-based care model and foster more open
communication to strengthen the relationships between Geisinger's
physicians and employees and the patients, families and communities
we serve. He has been instrumental in leading many of our signature
initiatives, including the redesign of Geisinger's primary care
model and the successful implementation of the Geisinger At Home
program.
Board Chairman John C. Bravman,
Ph.D., said, "Geisinger's greatest strength is our people, and we
are fortunate to have a proven leader in Dr. Ryu who is prepared to
step into the CEO role on an interim basis. Our Board places a
strong focus on developing talent throughout all levels of our
organization, with the goal of fostering leaders who embody our
core mission that has guided Geisinger for more than 100 years. Dr.
Ryu is a great example of this, and I and the other members of our
Board look forward to working with him and the entire leadership
team as Geisinger continues to deliver exceptional care to our
patients, our members and our communities."
Dr. Ryu commented, "When I joined Geisinger more than two years
ago, I knew I was joining an organization with a longstanding
national reputation for advancing medicine through innovation. What
I quickly discovered after I began working here, is that the
strength of Geisinger stems from our great people and communities.
As a practicing emergency medicine physician, I have the privilege
of working alongside many of our outstanding caregivers. That
firsthand view of their expertise and unwavering dedication
inspires me every day to keep my focus on our purpose of caring for
our patients, members, employees, physicians, students and the
communities we serve. I am honored to take on the role of interim
CEO at this important time for Geisinger and the healthcare
industry. Together with our outstanding leadership team and the
commitment of our 32,000 employees, we'll build on our legacy of
putting patients at the center of all that we do and maintain our
commitment to research, education and innovation."
Dr. Bravman added, "On behalf of the entire Geisinger Board and
family, we thank Dr. Feinberg for his exemplary leadership and
vision during his tenure as CEO. Dr. Feinberg has led Geisinger
through a significant period of transformation focusing on
developing innovative programs and models to further our mission of
value- and community-based care that ensures we are positioned to
serve our communities well into the future. We are deeply
appreciative of his service to Geisinger, and we wish him only the
best."
Dr. Feinberg said, "It has been a great privilege to lead
Geisinger during the past nearly four years. Together, we have
improved patient and member experience, along with our quality of
care, employee engagement and physician and nurse recruitment, and
our legacy of innovation has blossomed. I know that I am leaving
Geisinger in capable hands as the leadership team continues to
advance Geisinger's important mission of taking care of the people
we serve. I look forward to following Geisinger's achievements in
the years to come and will remain forever grateful to have had this
tremendous opportunity."
About Jaewon Ryu
A Diplomate of the American Board of Emergency Medicine, Dr. Ryu
has served as executive vice president and chief medical officer
for Geisinger since September 2016.
Dr. Ryu previously served as President of Integrated Care Delivery
for Humana in Louisville, Ky.,
where he was responsible for Humana's owned and joint ventured care
delivery practices, as well as Transcend, a management services
organization assisting affiliated practices to adopt population
health under value-based reimbursement.
Prior to Humana, he served as the chief medical officer at the
University of Illinois Hospital &
Health Sciences System in Chicago.
Dr. Ryu has also held various leadership roles at
Kaiser-Permanente, the Centers for Medicare and Medicaid Services
(CMS), and as a White House Fellow at the Department of Veterans
Affairs. He is an emergency medicine physician with a license to
practice in California,
Virginia, Maryland and the District of Columbia, and previously was an
associate attorney in the Los
Angeles office of the firm McDermott, Will & Emery
practicing corporate health law.
Dr. Ryu currently serves as a Commission Member for The Medicare
Payment Advisory Commission (MedPAC), an independent congressional
agency advising the U.S. Congress on issues affecting the Medicare
program. He also currently serves as a member of the board of
directors of MyHealthDirect, a provider of digital care
coordination solutions. Dr. Ryu has previously served in advisory
roles including board positions with MCCI Medical Group and
JenCare, both clinic/MSO organizations managing the financing and
delivery of care for Medicare Advantage members under full-risk
payment models. He has also served on the board of directors of the
White House Fellows Foundation and Association.
He earned his undergraduate degree from Yale University and his medical and law degrees
from The University of Chicago. Dr. Ryu
completed his internship and residency training in emergency
medicine at Harbor-UCLA Medical Center.
Dr. Ryu is the recipient of several honors and achievements,
including the co-author of a successful grant award of $19.5 million from CMS for a project that
integrated care teams across a network of 70 practices to enhance
coordination and efficiency in care delivery to chronically ill
populations.
About Geisinger
One of the nation's most innovative
health services organizations, Geisinger serves more than 1.5
million patients in Pennsylvania
and New Jersey. The system
includes 13 hospital campuses, a nearly 600,000-member health plan,
two research centers and the Geisinger Commonwealth School of
Medicine. Geisinger is known for its focus on caring and innovative
programs including the ProvenCare® best-practice approach to
maximize quality, safety and value; ProvenHealth Navigator®
advanced medical home; Springboard Health® population health
program to improve the health of an entire community;
ProvenExperience™ to provide refunds to patients unhappy with their
care experience; and Geisinger's MyCode® Community Health
Initiative, the largest healthcare system-based precision health
project in the world. With more than 215,000 volunteer participants
enrolled, MyCode is conducting extensive research and returning
medically actionable results to participants. A physician-led
organization, with approximately 32,000 employees and more than
1,800 employed physicians, Geisinger leverages an estimated
$12.7 billion positive annual impact
on the Pennsylvania and
New Jersey economies. Repeatedly
recognized nationally for integration, quality and service,
Geisinger has a long-standing commitment to patient care, medical
education, research and community service. For more
information, visit www.geisinger.org, or connect with us
on Facebook, Instagram, LinkedIn and Twitter.
CONTACT:
|
Don
Stanziano
|
|
570-214-9064 or
619-316-6580
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/geisinger-appoints-jaewon-ryu-md-as-interim-president-and-chief-executive-officer-300747259.html
SOURCE Geisinger